- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04558177
Repetitive Transcranial Stimulation to Treat Depression and Anxiety in Senior Inpatients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Purpose: To determine if using adjunctive TDCS to treat seniors admitted with symptoms of depression and anxiety reduces length of stay and improves quality of life. Hypothesis: Using transcranial direct current stimulation (TDCS) will decrease length of stay because it will reduce symptoms of depression and anxiety enabling patients to engage with their therapy sooner and more effectively. Justification: Anti-depressant or anti-anxiety medications are often used for this inpatient population but there are many reasons why alternative or adjunctive treatments may be desirable. Medications can take weeks to become effective, if they work at all. There are many potential side effects of medications, especially in an older population, including cognitive and other neurologic impairments. There is also an increasing resistance to a polypharmacy approach to treatment in this population. A low-risk, relatively non-invasive, easily applied and well-tolerated treatment to accelerate mood and anxiety disorder resolution would allow earlier and more effective engagement in rehabilitation therapy. This would in turn shorten lengths of stay and improve quality of life. Objectives: to determine if (1) TDCS reduces symptoms of depression and anxiety and (2) if patients in the intervention group are discharged from hospital sooner than those in the sham group. Research Method/Procedure: Direct current of 1.5 milliamp (mA) will be applied for 20 minutes 5x/week for 3 weeks in a hemispheric montage over the homologous dorso-lateral prefrontal cortices, anodal on the left. The Glenrose Rehabilitation Hospital is Canada's largest freestanding rehabilitation institution with programs and services for all age groups. Rehabilitation services cover all disciplines from physical, occupational therapy to social work. Older adults are admitted to 3D and 4C to address issues related to frailty such as weakness and poor balance which affect ability to undertake activities of daily living. Most of the services they receive as inpatients come from physical and occupational therapists with speech therapists and psychologists also available if needed.Patients will be drawn from these seniors admitted to these 2 geriatrics units, 3D and 4C. Candidates who meet the eligibility criteria and are interested in the project will be approached by the RA who is not involved in their care and will seek their consent. Patients will be randomized into standard care (SoC) plus active TDCS and SoC with sham TDCS. TDCS is unique in that effective double blind sham conditions can be created. Effectiveness of treatment will be judged primarily on reduced length of stay with improved Geriatric Depression Score (GDS), Geriatric Anxiety Score (GAS) and Older Person's Quality of Life (OPQOL) as secondary outcome measures. We expect that it will take ~8 months to complete the study: 3 months for ethics review, 4 months to enroll 100 of a possible 200 eligible patients and 1 for data analysis.
This intervention will be judged primarily on its effect on length of stay for this population. It is our working hypothesis that this intervention will shorten length of stay by approximately 5 days. It will do this because TDCS will improve depression (GDS less than 5/15) and anxiety symptoms (score less than 9/30) and thus increase motivation and engagement. Readiness to proceed with therapy is a clinical judgement based on patient demeanour and GDS made by the Unit team who will be blind with respect to whether the patient is receiving TDCS or part of the sham group. Data will include: demographics: gender, age and diagnosis. Geriatric Anxiety Inventory, Geriatric Depression and Quality of Life scales will be completed within 1 week of admission, and at ~ 3 and 5 weeks (+3 days) after intervention initiated. Testing will be coordinated with the Unit Occupational Therapist to avoid duplication or the risk of over testing.
Data analysis:
- Baseline group statistics (mean age &, standard deviation, male/female count, diagnostic frequencies, initial mean & standard deviations of GDS, Geriatric Anxiety Inventory and Quality of Life scores).
- Effect of length of stay: Student t test will be used to determine if there is a significant difference between the 2 groups, defined as p<0.05.
- Changes in Depression, anxiety or quality of life: significant differences from baseline at 3 and 5 weeks intervals will be assessed based on minimum clinical differences using a chi squared test.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T5G 0B7
- Glenrose Rehabilitation Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients above 65 years old
- a Geriatric Depression Score above 4
- cognitively sound enough to give consent
- know English well enough to understand the procedure
Exclusion Criteria:
- being treated for an infection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Stimulation Group
Will receive ~1.5mA transcranial stimulation for 20 minutes, 5x per week from a direct current stimulator
|
HDCprog connected to a direct current stimulator, controls the number of stimulations (maximum 99), the intensity (up to 1.5mA per channel), the duration (maximum 20min), and the minimum interval between two consecutive simulations (max 1168 hours).
A sham condition is also available which will ramp the stimulation to a preset maximum level and then immediately reduces the stimulation to 0.
|
Sham Comparator: Device placed only, no stim
Same as experimental group but the stimulation from the direct current stimulator will be initiated and then stopped
|
HDCprog connected to a direct current stimulator, controls the number of stimulations (maximum 99), the intensity (up to 1.5mA per channel), the duration (maximum 20min), and the minimum interval between two consecutive simulations (max 1168 hours).
A sham condition is also available which will ramp the stimulation to a preset maximum level and then immediately reduces the stimulation to 0.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of stay
Time Frame: average length of stay varies from 28 to 42 days
|
How long the patient is in hospital measured in days
|
average length of stay varies from 28 to 42 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Geriatric Depression Score
Time Frame: applied within 1 week of admission and then at 3 and 5 weeks
|
Survey assessing depression level of subject
|
applied within 1 week of admission and then at 3 and 5 weeks
|
Geriatric Anxiety Score
Time Frame: applied within 1 week of admission and then at 3 and 5 weeks
|
Survey assessing anxiety level of subject
|
applied within 1 week of admission and then at 3 and 5 weeks
|
Older Person Quality of Life Questionnaire
Time Frame: applied within 1 week of admission and then at 3 and 5 weeks
|
Survey assessing subject's impression of thier overall quality of life
|
applied within 1 week of admission and then at 3 and 5 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hubert Kammerer, MD, Alberta Health services
Publications and helpful links
General Publications
- Lefaucheur JP, Antal A, Ayache SS, Benninger DH, Brunelin J, Cogiamanian F, Cotelli M, De Ridder D, Ferrucci R, Langguth B, Marangolo P, Mylius V, Nitsche MA, Padberg F, Palm U, Poulet E, Priori A, Rossi S, Schecklmann M, Vanneste S, Ziemann U, Garcia-Larrea L, Paulus W. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol. 2017 Jan;128(1):56-92. doi: 10.1016/j.clinph.2016.10.087. Epub 2016 Oct 29.
- Figeys M, Villarey S, Leung AWS, Raso J, Buchan S, Kammerer H, Rawani D, Kohls-Wiebe M, Kim ES. tDCS over the left prefrontal Cortex improves mental flexibility and inhibition in geriatric inpatients with symptoms of depression or anxiety: A pilot randomized controlled trial. Front Rehabil Sci. 2022 Oct 25;3:997531. doi: 10.3389/fresc.2022.997531. eCollection 2022.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00078317
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Geriatric In-patients
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompletedNutritional Status in Hospitalised Geriatric Patients
-
Mohamed Sayed Mohamed AbbasCompletedSpinal Anesthesia | Total Knee Arthroplasty in Geriatric Patients
-
University of Erlangen-Nürnberg Medical SchoolAOK Bayern; Federal Joint Committee; Friedrich-Alexander-Universität Erlangen-Nürnberg and other collaboratorsCompletedGeriatric Patients in the Transition From Hospital to HomeGermany
-
Cairo UniversityUnknownGeriatric Patients
-
Charite University, Berlin, GermanyHomöopathie Stiftung; omoeon e.V.Completed
-
Alexandria UniversityRecruiting
-
End-of-Life Research GroupKU Leuven; Amsterdam UMC, location VUmc; Agentschap voor Innovatie door Wetenschap... and other collaboratorsCompletedOlder Patients Dying in Acute Geriatric Hospital WardsBelgium
-
Thomas Jefferson UniversityCompletedGeriatric Cancer PatientsUnited States
-
Tokat Gaziosmanpasa UniversityCompleted
-
Trabzon Kanuni Education and Research HospitalCompleted
Clinical Trials on Direct current stimulator
-
The University of New South WalesSingapore General HospitalCompleted
-
Federal University of ParaíbaUnknown
-
Seoul National University HospitalCompletedPrimary InsomniaKorea, Republic of
-
Spaulding Rehabilitation HospitalCompletedEpilepsy | SeizuresUnited States
-
Spaulding Rehabilitation HospitalHighland Instruments, Inc.CompletedOsteoarthritis | Chronic PainUnited States
-
Spaulding Rehabilitation HospitalSuspended
-
Spaulding Rehabilitation HospitalCompletedChronic Pain | Neuropathic Pain | Corneal PainUnited States
-
Spaulding Rehabilitation HospitalCompletedEffects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn InjuryPain | Burn InjuryUnited States
-
Spaulding Rehabilitation HospitalTerminatedChronic Pain | Spinal Cord InjuryUnited States